Ting Xiao

Exploring the molecular mechanisms and molecular markers of malignant tumor occurrence and development, focusing on clinical proteomics, dedicated to discovering biomarkers for tumor diagnosis, treatment and prognosis monitoring, discovering novel anti-tumor drug targets, and emphasizing the translation of research results into clinical applications.